Your browser doesn't support javascript.
loading
HAP score as prognostic factor of hepatocellular carcinoma treated with transarterial chemoembolization in a Latin American center.
Liza Baca, Estefanía; Díaz Ferrer, Javier.
Afiliação
  • Liza Baca E; Department of the Digestive System, Edgardo Rebagliati Martins National Hospital, EsSalud. Lima, Peru.
  • Díaz Ferrer J; Department of the Digestive System, Edgardo Rebagliati Martins National Hospital, EsSalud. Lima, Peru.
Rev Gastroenterol Peru ; 38(2): 164-168, 2018.
Article em En | MEDLINE | ID: mdl-30118463
INTRODUCTION: Hepatocellular carcinoma (HCC) in cirrhosis is diagnosed, most of times, when it is not susceptible to curative treatment. Transarterial chemoembolization (TACE) is a palliative therapeutic option with heterogeneous results. The HAP score stratifies patients who will benefit from the first TACE. OBJECTIVE: To evaluate if the HAP score is a prognostic factor of HCC treated with TACE. MATERIALS AND METHODS: Retrospective cohort study in cirrhotic patients with HCC and first TACE at the Edgardo Rebagliati Martins National Hospital, Lima-Peru, from June 2011 to June 20139. The HAP score was applied, mortality and survival were observed with a follow-up of 36 months. RESULTS: We included 54 patients with age of 67.7±9.9 years, 59.3% Child-Pugh A and 40.7% Child-Pugh B, MELD score of 11±2.7; 51.9 and 40.7% were BCLC A and B, respectively; 66.7% had a single tumor and 70.4% had a predominant tumor <5cm. The HAP score classified 8, 14, 26 and 6 patients as HAP A, B, C and D, respectively. The overall survival was 19.5±11.2 months and 32.8±6.5 months for HAP A, 24.9±14.8 months for HAP B, 13.9±5.2 months for HAP C and 14±6.6 months for HAP D. There were no deaths at 12 months in HAP A. At 24 months, mortality for HAP C and D was 100%. At 36 months, the survival rate for HAP A and B was 75 and 42.9%, respectively. CONCLUSIONS: The HAP score is a useful tool to guide the management decisions of cirrhotic patients with HCC requiring TACE due to its value in predicting mortality and survival.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Apoio para a Decisão / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Peru Idioma: En Revista: Rev Gastroenterol Peru Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Peru País de publicação: Peru
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Apoio para a Decisão / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Peru Idioma: En Revista: Rev Gastroenterol Peru Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Peru País de publicação: Peru